Associate Professor of Critical Care Medicine University of Texas MD Anderson Cancer Center Houston, Texas
Disclosure(s):
Cristina Gutierrez, MD: No relevant financial relationship(s) to disclose.
This session will focus on updates in emerging literature regarding management of alveolar hemorrhage, immunotherapy toxicities, and venous thromboembolism/anticoagulation management.
Learning Objectives:
Examine available therapies for hemoptysis and alveolar hemorrhage in critically ill oncology patients
Review updates in the management of CART-related toxicities.
Describe limitations to VTE management and anticoagulation considerations in the critically ill oncology patient.
